Advanced Oncotherapy (LSE:AVO) COGS-to-Revenue : 0.00 (As of Jun. 2022)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Oncotherapy COGS-to-Revenue?

Advanced Oncotherapy's Cost of Goods Sold for the six months ended in Jun. 2022 was £0.00 Mil. Its Revenue for the six months ended in Jun. 2022 was £0.00 Mil.

Advanced Oncotherapy's COGS to Revenue for the six months ended in Jun. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Advanced Oncotherapy's Gross Margin % for the six months ended in Jun. 2022 was N/A%.

Advanced Oncotherapy COGS-to-Revenue Historical Data

The historical data trend for Advanced Oncotherapy's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Oncotherapy COGS-to-Revenue Chart

Advanced Oncotherapy Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

COGS-to-Revenue

Get a 7-Day Free Trial

Advanced Oncotherapy Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Advanced Oncotherapy COGS-to-Revenue Calculation

Advanced Oncotherapy's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Advanced Oncotherapy's COGS to Revenue for the quarter that ended in Jun. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Advanced Oncotherapy (LSE:AVO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Advanced Oncotherapy's Gross Margin % for the six months ended in Jun. 2022 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Advanced Oncotherapy COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Advanced Oncotherapy's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Oncotherapy (LSE:AVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Oncotherapy PLC (LSE:AVO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Tenterden Street, Third Floor, London, GBR, W1S 1TE

Website

https://www.avoplc.com

Advanced Oncotherapy PLC is active in the healthcare domain in the United Kingdom. As a medical care provider, its focus is to develop technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to healthy tissues. It develops an affordable proton-based radiotherapy system, using innovative and clinically effective technology, thereby contributing to curing critical unmet conditions. The company's only business segment is Proton Therapy.